Amarin Corp Plc (AMRN)

[JRoon71]

Amarin should sell the brand to BP and retain the rights to the generic, and form a buying alliance with them for API.

This would help Amarin, the shareholders, and the BP.

Amarin could eliminate most of its overhead and just sell the generic IE at a MUCH higher profit than currently (because there would be virtually no overhead, and API would be cheaper).

BP could sell the brand, along with it's next iteration of drug (MND-2119, FDC, etc.).